10-K: Target Group Inc. Reports Revenue Growth and Income for Fiscal Year 2024, but Going Concern Doubts Remain

Target Group Inc. reports increased revenue and income for 2024, but faces a working capital deficit and auditor concerns about its ability to continue as a going concern.

Summary

• Target Group Inc. reported revenue of $6,591,625 and income of $160,504 for the year ended December 31, 2024.
• The company has a working capital deficit of $9,994,548 and an accumulated deficit of $30,946,844.
• The company's independent auditors have raised substantial doubt about its ability to continue as a going concern.
• The company's continuation as a going concern is dependent on generating cash flow, receiving financial support from stockholders, and obtaining equity financing.
• The company is engaged in the cultivation, processing, and distribution of cannabis products in Canada.
• The company completed strategic acquisitions, including Visava Inc./Canary Rx Inc. and CannaKorp Inc.
• The company has a Distribution, Collaboration and Licensing Agreement with Serious Seeds B.V.
• The company terminated a Joint Venture Agreement with Thrive Cannabis, consolidating JVCo as a wholly-owned subsidiary.
• The company has a Debt Purchase and Assignment Agreement with CL Investors Inc., a related party.
• The company faces risks related to the cannabis business, including regulatory changes, competition, and operational challenges.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While revenue and income increased, the going concern warning and working capital deficit raise significant concerns. The ineffective internal controls further dampen the outlook.

Positives

• The company generated revenue of $6,591,625 during the current year, an increase from $3,720,169 in the comparable year ended in 2023.
• The company reported net income of $160,504 for the year ended December 31, 2024.
• Operating activities provided cash of $2,162,684 compared to the cash used of $589,612 during the prior year.
• The company has an ongoing strategic partnership with Dutch breeder, Serious Seeds B.V. (Serious Seeds), to cultivate exclusive, world-class proprietary genetics.

Negatives

• The company has a working capital deficit of $9,994,548 and an accumulated deficit of $30,946,844.
• The company's independent auditors have issued a report raising substantial doubt about the company's ability to continue as a going concern.
• The company is in breach of the loan agreement with a related party as at year end.
• The company's internal control over financial reporting was not effective as of December 31, 2024.

Risks

• The company's proposed business is dependent on laws pertaining to the marijuana industry.
• Cannabis remains illegal under U.S. federal law.
• Laws and regulations affecting the cannabis industry are constantly changing, which could detrimentally affect the company's business.
• The recreational adult-use cannabis market in Canada may become oversupplied following the implementation of the Cannabis Act.
• The company may not be able to attract or retain key personnel with sufficient experience in the cannabis industry.
• The company faces intense competition, may have limited access to services of banks, may have substantial burdens on company resources due to litigation, complaints or enforcement actions and are heavily dependent on receiving necessary permits and authorization to engage in the cultivation, possession or distribution of cannabis.
• The company is subject to cybersecurity risks such as system disruption, theft and the release of confidential information.

Future Outlook

The company anticipates that its future operations will generate positive cash flows starting in 2024 and it has generated $2,162,684 cash from operations for the year ended December 31, 2024. The Company is actively seeking various financing operations to meet the working capital requirements.

Management Comments

• Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 COSO Framework or COSO).
• Based on this evaluation, management has concluded that our internal control over financial reporting was not effective as of December 31, 2024.

Industry Context

The company operates in the cannabis industry, which is subject to evolving regulations and increasing competition. The legalization of cannabis in Canada has created opportunities but also challenges related to oversupply and regulatory compliance.

Comparison to Industry Standards

• It is difficult to compare Target Group Inc.'s results directly to industry standards due to its unique business model and smaller size compared to major cannabis players like Canopy Growth Corporation, Aurora Cannabis, or Tilray.
• However, the company's revenue growth suggests it is gaining traction in the Canadian cannabis market.
• The company's financial challenges, including the working capital deficit and going concern doubts, are not uncommon among smaller cannabis companies facing regulatory hurdles and intense competition.
• Compared to companies like Organigram Holdings Inc. and Cronos Group Inc., Target Group Inc. has a smaller market capitalization and revenue base.
• The company's focus on wholesale and co-packaging services differentiates it from companies primarily focused on retail sales.

Legal Proceedings

• A terminated employee of Canary has filed a lawsuit against the Company amounting to approximately $1,459,500 (CAD 2,100,000) in Ontario, Canada.
• A complaint for damages of $150,000 was lodged against CannaKorp by the former Chief Financial Officer of CannaKorp for outstanding professional fees.
• A claim for damages of $1,294,649 (CAD 1,862,805) was lodged against Company and its directors by the former Chief Financial Officer of the Company for wrongful dismissal.
• A claim for damages of $90,891 (CAD 130,778) was lodged against Canary by a vendor for breach of contract.

Related Party Transactions

• The CEO of the Company is a director of the Company, the Secretary of CLI, a shareholder of CLI and the brother of the CEO is the President and sole director of CLI therefore the loan from CLI is classified under related party transactions.
• Jerry Zarcone, the brother of Anthony Zarcone, the Chief Executive Officer (CEO) and a director of the Company, entered into a loan agreement with the Company pursuant to which Jerry Zarcone agreed to loan the Company up to $1,936,534 (CAD 2,786,380) for working capital purposes.

Stakeholder Impact

• Shareholders face uncertainty due to the going concern warning and financial challenges.
• Employees' job security is potentially at risk due to the company's financial instability.
• Customers may be affected if the company's operations are disrupted.
• Suppliers and creditors face increased risk of non-payment.

Next Steps

• The company will require additional working capital from either cash flow from operations, sale of its equity or issuance of debt.
• The company is under discussions to formalize the arrangements with the lender to revise the terms of the loans.

Key Dates

Keywords

cannabis, cultivation, revenue, going concern, Canada, Visava, CannaKorp, Serious Seeds, JVCo, debt, regulation